For the year ending 2025-12-31, ZBH had $66,400K increase in cash & cash equivalents over the period. $1,472,600K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net earnings | 705,100 | 905,200 | 1,025,100 | 291,200 |
| Depreciation and amortization | 1,093,800 | 996,300 | 951,700 | 926,400 |
| Share-based compensation | 90,200 | 101,000 | 99,800 | 105,000 |
| Goodwill and intangible asset impairment | - | - | - | 292,800 |
| (gain) loss on investment in zimvie inc | - | 0 | 2,500 | -116,600 |
| Deferred income tax benefit | -87,200 | -47,700 | -96,300 | -64,400 |
| Income taxes | -166,600 | -158,600 | -73,800 | -152,900 |
| Receivables | 127,300 | 89,700 | 51,900 | 184,700 |
| Inventories | -98,200 | -49,900 | 240,400 | 75,600 |
| Accounts payable and accrued liabilities | 101,800 | -322,000 | -55,300 | 103,000 |
| Other assets and liabilities | 11,000 | -65,000 | -25,200 | 1,200 |
| Net cash provided by operating activities from continuing operations | - | 1,499,400 | 1,581,600 | 1,356,200 |
| Net cash provided by operating activities | 1,697,100 | - | - | - |
| Additions to instruments | 300,500 | 240,300 | 311,700 | 258,300 |
| Additions to other property, plant and equipment | 224,500 | 203,800 | 291,100 | 187,900 |
| Net investment hedge settlements | 400 | -22,100 | -33,400 | -89,400 |
| Acquisition of intangible assets | 52,400 | 153,000 | 86,400 | - |
| Business combination investments, net of acquired cash | 1,393,200 | 276,300 | 134,900 | 99,800 |
| Other investing activities | 4,600 | 36,900 | -11,800 | 65,400 |
| Net cash used in investing activities from continuing operations | - | -888,100 | -778,900 | -522,000 |
| Proceeds from multicurrency revolving facility | - | - | - | 595,000 |
| Net (payments) proceeds on revolving facilities | - | -50,000 | -325,000 | - |
| Net cash used in investing activities | -1,975,700 | - | - | - |
| Payments on multicurrency revolving facility | - | - | - | 220,000 |
| Proceeds from senior notes | 2,492,100 | 1,436,300 | 499,800 | - |
| Redemption of senior notes | 1,463,000 | 850,000 | 86,300 | 1,275,800 |
| Proceeds from term loan | - | 0 | - | 83,000 |
| Payments on term loans | - | 0 | 33,900 | 242,900 |
| Dividends paid to stockholders | 190,300 | 196,000 | 200,900 | 201,200 |
| Proceeds from employee stock compensation plans | 39,700 | 82,100 | 101,100 | 78,100 |
| Distribution from zimvie, inc | - | - | - | 540,600 |
| Business combination contingent consideration payments | 25,000 | 3,500 | 10,300 | - |
| Debt issuance costs | 22,700 | 13,000 | 5,800 | 1,600 |
| Deferred business combination payments | - | - | 4,000 | - |
| Repurchase of common stock | 487,000 | 868,000 | 692,200 | 126,400 |
| Other financing activities | -17,700 | -22,400 | -6,100 | -4,500 |
| Net cash used in financing activities from continuing operations | - | -484,500 | -763,500 | -775,700 |
| Net cash used in operating activities | - | 0 | 0 | -71,500 |
| Net cash used in investing activities | - | 0 | 0 | -7,200 |
| Net cash used in financing activities | - | 0 | 0 | -68,100 |
| Net cash used in discontinued operations | - | 0 | 0 | -146,800 |
| Net cash provided by (used in) financing activities | 326,000 | - | - | - |
| Effect of exchange rates on cash and cash equivalents | 19,000 | -17,100 | 900 | -14,500 |
| Increase in cash and cash equivalents | 66,400 | 109,700 | 40,100 | -102,800 |
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
ZIMMER BIOMET HOLDINGS, INC. (ZBH)